Kailera Therapeutics, Inc. (KLRA)
Nasdaq: KLRA · Pharmaceutical Preparations · filing with the SEC since 2025
Who runs Kailera Therapeutics, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedChief executive, as filed
Renaud Ronald C Jr
CEO & President. First filing Apr 2026, latest Jun 11, 2026, 0 filings in all.
Officers reporting now
9
of 16 people with a filing in the last fifteen months
Directors reporting now
7
16 people on the record since 2026
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Title as filed | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Nicholson Nur | Chief Technology Officer | Sep 2026 | Sep 9, 2026 | none |
| Tregoning Kathleen | Chief Corporate Affairs Officer | Jul 2026 | Jul 8, 2026 | none |
| Renaud Ronald C Jr | CEO & President | Apr 2026 | Jun 11, 2026 | none |
| Pagan Douglas W. | Chief Financial Officer | Apr 2026 | Apr 20, 2026 | none |
| Burgess Paul D. | Chief Operating Officer & Chief Business Officer | Apr 2026 | Apr 20, 2026 | none |
| Akamine Scott | Chief Legal Officer | Apr 2026 | Apr 20, 2026 | none |
| Cloghessy Paula | Chief People Officer | Apr 2026 | Apr 20, 2026 | none |
| Coleman Jamie Beth | Chief Commercial Officer | Apr 2026 | Apr 20, 2026 | none |
| Wasserman Scott M. | Chief Medical Officer | Apr 2026 | Apr 20, 2026 | none |
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Clyburn Frank | director | Apr 2026 | Apr 20, 2026 | none |
| Hite Christopher | director | Apr 2026 | Apr 20, 2026 | none |
| Kaplan Andrew T. | director | Apr 2026 | Apr 20, 2026 | none |
| Koppel Adam | director | Apr 2026 | Apr 20, 2026 | none |
| Mackay Martin | director | Apr 2026 | Apr 20, 2026 | none |
| Milligan John F | director | Apr 2026 | Apr 20, 2026 | none |
| Liu Yuting | director | Apr 2026 | Apr 16, 2026 | none |
Owners of more than 10% of a classsales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. | 10% owner | Apr 2026 | Apr 22, 2026 | none |
| Rtw Investments, LP | 10% owner | Apr 2026 | Apr 22, 2026 | none |
| Wong Roderick | 10% owner | Apr 2026 | Apr 22, 2026 | none |
| Bain Capital Fund Xiv, L.P. | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bain Capital Investors LLC | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bain Capital Life Sciences Fund IV, L.P. | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bain Capital Life Sciences Investors, LLC | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bain Capital Life Sciences IV General Partner, LLC | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bain Capital Xiv General Partner, LLC | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bcls Fund IV Investments Gp, LLC | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bcls Fund IV Investments, L.P. | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bcpe Perseus Investor Gp, LLC | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Bcpe Perseus Investor, LP | 10% owner | Apr 2026 | Apr 20, 2026 | none |
| Canada Pension Plan Investment Board | 10% owner | Apr 2026 | Apr 16, 2026 | none |
| Cpp Investment Board Private Holdings (4) Inc. | 10% owner | Apr 2026 | Apr 16, 2026 | none |
| Stuart Partners, LLC | 10% owner | Apr 2026 | Apr 16, 2026 | none |
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.